This is interesting: The Right-to-Try Revolt Terminally

New Post Public Reply Private Reply Replies (0) Message Board
knack
This is interesting: The Right-to-Try Revolt

Terminally ill patients are fed up with slow FDA drug approvals.

It should not go unnoticed that last week the Food and Drug Administration announced it would “simplify and accelerate” the application process for “unapproved investigational drugs” that have passed Phase I safety trials. We are back on the most contentious ground of FDA drug approval, involving the most desperate, terminally ill patients.

The current form used by such patients for access to unapproved drugs is so complex that it takes about 100 hours to complete it and requires seven attachments. The new form will take 45 minutes, asks attending physicians to fill in eight pieces of patient information and requires one attachment.


For sick patients seeking access to experimental drugs this would appear to rank with Moses parting the Red Sea. It is surely less than that, but patient groups already know it takes an army to move the FDA bureaucracy. So-called “compassionate-use” protocols exist mainly because in 1988 some 1,000 people from the AIDS advocacy group called ACT Up marched on and surrounded the FDA’s main building in Rockville, Md. The FDA bent.

No such mass movement exists today for seriously ill people, who of late have turned to state legislatures to enact so-called “right to try” laws. Last year, at the urging of grassroots groups like the Goldwater Institute, five states enacted such laws with wide bipartisan majorities. Another 26 states, including California and Florida, may follow.

More than anything, the FDA’s bureaucrats have proven they are politically astute. The right-to-try laws do not eliminate the FDA’s regulatory authority. The state laws essentially say that patients and their doctors may seek to use drugs that have passed the FDA’s first phase of safety tests. Right-to-try laws allow patients and doctors to negotiate directly with drug companies for access to experimental drugs.

The agency said last week it’s “committed to streamlining its processes,” but the more likely explanation is that the bureaucracy felt pressured by a groundswell of frustrated patients. As with the AIDS era’s creation of compassionate use, the spreading popularity of these new state-based access laws has the makings of a movement that could eventually find its way to Congress.

That is where the FDA’s control of the American drug-development process could come under real pressure, if Republicans in 2017 control both Congress and the Presidency. Most likely, the FDA recognized it had to do something to slow down the right-to-try political juggernaut. Whatever its improvements, the new form still keeps the process under FDA control.

The issue of access to experimental drugs for terminally ill patients is fraught with moral, ethical, scientific and economic concerns. Drug makers, especially smaller biotechnology companies, can feel caught between patients on one side and an FDA approval process that can cost at least $1 billion before a single sale of the new drug. None of those issues will disappear.

We’re not going to look a gift horse in the mouth. Whether the decision to expedite access means the agency knows its processes are broken or is merely an act of bureaucratic realpolitik, the long battle to help the nation’s sickest patients has moved forward again—and at last.
http://investorstemcell.com/forum/ocata-main-.../49571.htm

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 109

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading
Payoneer Gets OCC Nod, but the Finish Line Is Ahead

Updated Category News Views 121

Federal bank paperwork is not usually thrilling, yet Payoneer just found a potentially meaningful lever for its cross-border payments machine. The company received preliminary conditional approval from the Office of the Comptroller of the Currency to form PAYO Digital Bank, a national trust bank intended to support stablecoin services. That is a real regulatory milestone...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 91

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 69

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 83

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
AMD Faces Fresh Scrutiny Over China Supply Exposure

Updated Category News Views 130

One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 67

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading

Top 5 Most Recently Viewed Articles

Carvana's Stock Peaks at $187.37 Amid Renewed Investor Confidence

Updated Category News Views 79

Carvana's Impressive Stock Surge to 52-Week High Recently, Carvana Co (NYSE: CVNA) achieved a remarkable milestone by hitting a 52-week high of $187.37. This surge highlights a robust recovery for the online used car retailer, whose stock has skyrocketed by an impressive 377.82% over the past year. This surge in stock price signifies renewed investor confidence in...

Continue Reading
ABM Industries Closes Q3 with Strong Earnings and Growth Boost

Updated Category News Views 133

ABM Industries Reports Strong Q3 Earnings ABM Industries (NYSE: ABM) saw its share price jump nearly 7% following the announcement of its third quarter earnings, which exceeded analyst expectations and prompted an upgrade to its full-year guidance. This positive outcome underscores the company's resilience in a challenging market landscape. Robust Financial Performance In...

Continue Reading
Transforming Senior Care: Click Holdings Embraces Cryptocurrency

Updated Category News Views 144

Innovative Strategies in Senior Care by Click Holdings Limited Click Holdings Limited (NASDAQ: CLIK) is making headlines with its groundbreaking approach to enhancing senior care services. Based in Hong Kong, this company combines cutting-edge human resources solutions with innovative cryptocurrency strategies, aiming to redefine how care services operate in an evolving...

Continue Reading
Cypress Creek and Meta Join Forces for Major Solar Project

Updated Category News Views 360

Cypress Creek and Meta's Renewable Energy Partnership In an exciting development, Cypress Creek Renewables and Meta have reached a significant milestone through their new Environmental Attribute Purchase Agreement (EAPA). This agreement is set to pave the way for the construction of a massive 505MWdc solar facility named Hanson Solar. With a capacity of 396MWac, this...

Continue Reading
The Shipyard Sets Sail with San Diego Headquarters Expansion

Updated Category News Views 462

The Shipyard Sets Sail with San Diego Headquarters Expansion The Shipyard, one of the fastest-growing independent marketing agencies in the nation, has announced an exciting development. The agency is expanding its operations by opening a new headquarters located in downtown San Diego at 185 West F Street. This move signifies a deepening of their commitment to California,...

Continue Reading